2021
DOI: 10.1111/jgh.15385
|View full text |Cite
|
Sign up to set email alerts
|

Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis

Abstract: Artificial intelligence (AI) has become increasingly widespread in our daily lives, including healthcare applications. AI has brought many new insights into better ways we care for our patients with chronic liver disease, including non‐alcoholic fatty liver disease and liver fibrosis. There are multiple ways to apply the AI technology on top of the conventional invasive (liver biopsy) and noninvasive (transient elastography, serum biomarkers, or clinical prediction models) approaches. In this review article, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(32 citation statements)
references
References 32 publications
0
31
0
1
Order By: Relevance
“…These machine learning models allow researchers to include any number of clinical, laboratory, and demographic features to detect hidden patterns for disease classification. While an extensive revision of literature is beyond the scope of our current study, a recent publication [ 22 ] reviewed and discussed advantages and disadvantages of the most frequently used algorithms and other aspects of data (both EHR and imaging). Sowa et al [ 23 ] included EHR of 126 patients to develop a final model with an accuracy of 0.79.…”
Section: Introductionmentioning
confidence: 99%
“…These machine learning models allow researchers to include any number of clinical, laboratory, and demographic features to detect hidden patterns for disease classification. While an extensive revision of literature is beyond the scope of our current study, a recent publication [ 22 ] reviewed and discussed advantages and disadvantages of the most frequently used algorithms and other aspects of data (both EHR and imaging). Sowa et al [ 23 ] included EHR of 126 patients to develop a final model with an accuracy of 0.79.…”
Section: Introductionmentioning
confidence: 99%
“…In this study, for each patient, 28 fluence maps were measured, and there were 1120 fluence maps in total. After classification, there were less maps corresponding to each label, the size of the data set (40 patients) used as CNN input may have been insufficient for the network, as CNNs generally require large-scale datasets for training (43,44); as a result, the advantage of using the CNNs was not obvious. In this study, a method to identify position errors was developed by analyzing the EPID fluence maps, which can be combined with CBCT in clinical treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Besides, Wong comprehensively evaluated non-alcoholic fatty liver disease severity based on clinical information, including electronic health records, liver biopsies, and liver images [ 110 ]. In future, AI health assessment of patients may not be limited to cross-sectional studies.…”
Section: Overviewmentioning
confidence: 99%